Skip to content
Medical Health Aged Care

Byron Medical Announces the Product Release of BlancOne: a Science-Powered Breakthrough Redefining In-Chair Whitening Technology

Byron Medical Pty Ltd 2 mins read

BRISBANE, Australia, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Byron Medical is excited to announce their exclusive distribution of BlancOne, a system developed with cutting-edge photochemistry and biophotonics that is rewriting the rules of professional whitening. Gone are the 60-minute sessions, uncomfortable gingival barriers, and days of post-op sensitivity. Instead, patients achieve noticeably whiter smiles - up to 5 VITA shades brighter - after a single 10-minute treatment, with no pain and no sensitivity.

Science That Shines: The Power of Photons Over Peroxide

Traditional whitening relies heavily on high concentrations of hydrogen peroxide - often causing enamel dehydration and post-treatment sensitivity in nearly 50% of patients, but BlancOne Click+ takes a different path.

Using a third-generation LightSpeed photochemical system, Click+ harnesses the power of light to activate a non-radical, highly targeted oxidising molecule - singlet oxygen that lifts deep-set stains without damaging the enamel. This breakthrough method is clinically proven to deliver dramatic whitening, while also supporting remineralisation with added nano-hydroxyapatite and vitamin complexes.

It’s Not Just Whitening - It’s a Clinical Breakthrough

BlancOne Click+ offers evidence-based innovation in a form that’s simple, stunning, and sustainable - giving dentists a new standard in chairside whitening and patients a reason to smile bigger, sooner.

Part of a Complete Whitening Ecosystem

Click+ is the gateway to BlancOne’s full whitening suite, including:

  • Touch+ - For deeper shade corrections with no gingival barrier
  • Ultra+ - For more stubborn or complex stains (requires a gingival barrier)
  • Home+ - A 6% HP take-home option for ongoing maintenance
  • Retail add-ons like whitening pens and pastes for continued results and patient engagement

About BlancOne

BlancOne is an Italian-born innovator in dental whitening technologies, known for merging scientific rigour with cosmetic excellence. Distributed exclusively by Byron Medical in Australia, BlancOne is committed to delivering safer, smarter, and more accessible whitening solutions for every practice.

Demos available now.

Contact your Byron Medical Representative or visit www.byronmedical.com.au/lp/blancone to learn more. Now Available Across Australia & New Zealand.

Media Contact:
Tom Mittelman
Marketing Manager, Byron Medical
+61 7 3472 9159
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/fd62ef28-32e6-4549-b3fb-8b62fd2d6dbf


More from this category

  • Animal Animal WelfareRights, Medical Health Aged Care
  • 26/02/2026
  • 06:00
Animal-Free Science Advocacy (AFSA)

Parliamentary petition urges equal protections for all primates used in research

Key Facts: AFSA is calling for public support for Australian Parliament e-petition EN8985 to extend stronger ethical protections to all non-human primates used in…

  • Contains:
  • Medical Health Aged Care
  • 26/02/2026
  • 06:00
Alcoholics Anonymous Australia

Alcoholics Anonymous Australia holds 60th National Convention on the Gold Coast

Alcoholics Anonymous Australia holds 60th National Convention on the Gold Coast Surfers Paradise,QLD Alcoholics Anonymous (AA) Australia will hold its 60th National Convention from May 1–4, 2026, at the JW Marriott Gold Coast Resort & Spa. The event, themed “Steps to Recovery,” brings together members from across the country and from overseas to share their collective experience in recovering from alcoholism. Event Information: What: 2026 AA National Convention When: May 1–4, 2026 (PI Meeting: Friday, May 1, 5:00 PM) Where: JW Marriott Gold Coast Resort & Spa, 158 Ferny Ave, Surfers Paradise Contact: Marg (PI Enquiries) at 0434 614 702…

  • Medical Health Aged Care
  • 25/02/2026
  • 17:12
Galderma

Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics

Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane®syringe for use with a range…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.